Release Date: 11/09/23 12:48 Summary: Management Fee Reduction - SEMI Price Sensitive: No Download Document 174.13KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%